These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3034631)

  • 1. Kappa-opiate-induced diuresis and changes in blood pressure: demonstration of receptor stereoselectivity using (+)- and (-)-tifluadom.
    Ureta H; López LF; Pérez A; Huidobro-Toro JP
    Eur J Pharmacol; 1987 Mar; 135(3):289-95. PubMed ID: 3034631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa-opioid diuretic effects of tifluadom, a benzodiazepine opioid agonist.
    Leander JD
    J Pharm Pharmacol; 1984 Aug; 36(8):555-6. PubMed ID: 6148404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tifluadom-induced diuresis in rats. Evidence for an opioid receptor-mediated central action.
    Shearman GT; Tolcsvai L
    Neuropharmacology; 1986 Aug; 25(8):853-6. PubMed ID: 3022178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the two isomers of the opioid benzodiazepine tifluadom with mu-, delta-, and kappa-binding sites and their analgesic and intestinal effects in rats.
    Petrillo P; Amato M; Tavani A
    Neuropeptides; 1985 Feb; 5(4-6):403-6. PubMed ID: 2860598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of opioid receptor sub-types in tifluadom-induced feeding.
    Jackson HC; Sewell RD
    J Pharm Pharmacol; 1984 Oct; 36(10):683-6. PubMed ID: 6150086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the opioid-benzodiazepine, tifluadom, on ingestive behaviors.
    Morley JE; Levine AS; Grace M; Kneip J; Zeugner H
    Eur J Pharmacol; 1983 Sep; 93(3-4):265-9. PubMed ID: 6315453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tifluadom on food consumption compared with chlordiazepoxide and kappa agonists in the rat.
    Cooper SJ; Moores WR; Jackson A; Barber DJ
    Neuropharmacology; 1985 Sep; 24(9):877-83. PubMed ID: 2997653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benzodiazepine (+)-tifluadom (KC-6128), but not its optical isomer (KC-5911) induces opioid kappa receptor-related EEG power spectra and evoked potential changes.
    Freye E; Boeck G; Schaal M; Ciaramelli F
    Pharmacology; 1986; 33(5):241-8. PubMed ID: 3025899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
    Salas SP; Roblero JS; López LF; Tachibana S; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1992 Sep; 262(3):979-86. PubMed ID: 1356155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels.
    Leander JD; Hart JC; Zerbe RL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):33-9. PubMed ID: 3039112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa-opiates and urination: pharmacological evidence for an endogenous role of the kappa-opiate receptor in fluid and electrolyte balance.
    Huidobro-Toro JP; Parada S
    Eur J Pharmacol; 1984 Dec; 107(1):1-10. PubMed ID: 6098480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the adrenomedullary dependence of kappa-opioid agonist-induced diuresis in conscious rats.
    Borkowski KR
    Br J Pharmacol; 1989 Dec; 98(4):1151-6. PubMed ID: 2558758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of opiates on urine output in the water-loaded rat and reversal by beta-funaltrexamine.
    Skingle M; Hayes AG; Tyers MB
    Neuropeptides; 1985 Feb; 5(4-6):433-6. PubMed ID: 2987740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa-opioid agonist induced diuresis. Is it mediated by a blood-borne factor of adrenomedullary origin?
    Borkowski KR
    Can J Physiol Pharmacol; 1989 Oct; 67(10):1219-24. PubMed ID: 2558784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa-opioid-receptor agonists modulate the renal excretion of water and electrolytes in anaesthetized rats.
    Ashton N; Balment RJ; Blackburn TP
    Br J Pharmacol; 1990 Jan; 99(1):181-5. PubMed ID: 2158834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tifluadom, a kappa-opiate agonist, acts as a peripheral cholecystokinin receptor antagonist.
    Chang RS; Lotti VJ; Chen TB; Keegan ME
    Neurosci Lett; 1986 Dec; 72(2):211-4. PubMed ID: 3027627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.